Therapeutic Areas Main Article
Daiichi Sankyo, Inc. accepts requests for CME programs in the following therapeutic areas:
- Acute myeloid leukemia (AML)
- Breast cancer, specifically HER2+/HER2-low expressing disease
- Tenosynovial giant cell tumor (TGCT)
Daiichi Sankyo, Inc. is aware of the growing need for support. Many more requests are received than can be funded, and we regret that we cannot accommodate every request. Every request receives a fair review, but in return we ask that you evaluate whether your request fits within our guidelines for submission.
Daiichi Sankyo, Inc. reserves the right to modify, revise or delete therapeutic areas of interest at any time without notice.